201 related articles for article (PubMed ID: 33847621)
21. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
Li YF; Zhang QQ; Wang WL
Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
[TBL] [Abstract][Full Text] [Related]
23. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
Xu Y; Huang T; Mao M; Zhai J; Chen J
Laryngoscope; 2021 Apr; 131(4):E1130-E1138. PubMed ID: 32833262
[TBL] [Abstract][Full Text] [Related]
24. Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database.
Deng C; Wu SG; Tian Y
Med Sci Monit; 2019 May; 25():3636-3646. PubMed ID: 31095532
[TBL] [Abstract][Full Text] [Related]
25. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
26. A Population-Based Systematic Clinical Analysis With a Single-Center Case Series of Patients With Pulmonary Large Cell Neuroendocrine Carcinoma.
Sun X; Wu Y; Shen J; Han C; Kang K; Liu Z; Zhang F
Front Endocrinol (Lausanne); 2021; 12():759915. PubMed ID: 34925232
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
Yamada Y; Beltran H
Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
[TBL] [Abstract][Full Text] [Related]
28. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
[TBL] [Abstract][Full Text] [Related]
31. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
Tsai HK; Lehrer J; Alshalalfa M; Erho N; Davicioni E; Lotan TL
BMC Cancer; 2017 Nov; 17(1):759. PubMed ID: 29132337
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis.
Wang HT; Yao YH; Li BG; Tang Y; Chang JW; Zhang J
J Clin Oncol; 2014 Oct; 32(30):3383-90. PubMed ID: 25225419
[TBL] [Abstract][Full Text] [Related]
33. Disadvantage of survival outcomes in widowed patients with colorectal neuroendocrine neoplasm: an analysis of surveillance, epidemiology and end results database.
Li J; Wang Y; Han F; Wang Z; Xu L; Tong J
Oncotarget; 2016 Dec; 7(50):83200-83207. PubMed ID: 27825123
[TBL] [Abstract][Full Text] [Related]
34. The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
Dong M; Gu X; Ma T; Mi Y; Shi Y; Fan R
Sci Prog; 2021; 104(2):368504211009336. PubMed ID: 33848229
[TBL] [Abstract][Full Text] [Related]
35. Distant organ metastasis patterns and prognosis of neuroendocrine cervical carcinoma: a population-based retrospective study.
Li Q; Yu J; Yi H; Lan Q
Front Endocrinol (Lausanne); 2022; 13():924414. PubMed ID: 36051393
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
Chen Z; Liu J; Min L
BMC Pulm Med; 2022 Mar; 22(1):116. PubMed ID: 35361152
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
[TBL] [Abstract][Full Text] [Related]
40. Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database.
Wang J; Wei B; Albarracin CT; Hu J; Abraham SC; Wu Y
BMC Cancer; 2014 Mar; 14():147. PubMed ID: 24589259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
